Clinical Trial Update: Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a busulfan plus melphalan conditioning regimen for lymphoid malignancies and multiple myeloma; the study completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)
• Melphalan (Melphalan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-01-19